151 related articles for article (PubMed ID: 33526873)
1. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group.
Weinberg OK; Chisholm KM; Ok CY; Fedoriw Y; Grzywacz B; Kurzer JH; Mason EF; Moser KA; Bhattacharya S; Xu M; Babu D; Foucar K; Tam W; Bagg A; Orazi A; George TI; Wang W; Wang SA; Arber DA; Hasserjian RP
Mod Pathol; 2021 Jul; 34(7):1358-1366. PubMed ID: 33526873
[TBL] [Abstract][Full Text] [Related]
2. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
4. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
5. CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features.
Lin CW; Liu TY; Chen SU; Wang KT; Medeiros LJ; Hsu SM
Blood; 2005 Nov; 106(10):3567-74. PubMed ID: 16046525
[TBL] [Abstract][Full Text] [Related]
6. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
Owatari S; Otsuka M; Takeshita T; Mizukami K; Suzuki S; Uozumi K; Tashiro Y; Arima N; Hanada S
Int J Hematol; 2009 Mar; 89(2):188-194. PubMed ID: 19109730
[TBL] [Abstract][Full Text] [Related]
7. Nasal CD56 positive small round cell tumors. Differential diagnosis of hematological, neurogenic, and myogenic neoplasms.
Liu Q; Ohshima K; Sumie A; Suzushima H; Iwasaki H; Kikuchi M
Virchows Arch; 2001 Mar; 438(3):271-9. PubMed ID: 11315624
[TBL] [Abstract][Full Text] [Related]
8. Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity.
Paietta E; Neuberg D; Richards S; Bennett JM; Han L; Racevskis J; Dewald G; Rowe JM; Wiernik PH;
Am J Hematol; 2001 Mar; 66(3):189-96. PubMed ID: 11279625
[TBL] [Abstract][Full Text] [Related]
9. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
11. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.
Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Suefuji H; Suzumiya J; Harada M; Kikuchi M
Am J Surg Pathol; 2003 Oct; 27(10):1366-74. PubMed ID: 14508398
[TBL] [Abstract][Full Text] [Related]
12. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
13. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
14. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
[TBL] [Abstract][Full Text] [Related]
15. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
Zhang K; Prichard JW; Brown RE
Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
[TBL] [Abstract][Full Text] [Related]
16. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
[TBL] [Abstract][Full Text] [Related]
17. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
[TBL] [Abstract][Full Text] [Related]
18. CD56-positive acute lymphoblastic leukemia.
Matano S; Terahata S; Nakamura S; Kobayashi K; Sugimoto T
Acta Haematol; 2005; 114(3):160-3. PubMed ID: 16227680
[TBL] [Abstract][Full Text] [Related]
19. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
Liu XY; Atkins RC; Feusner JH; Rowland JM
Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
[TBL] [Abstract][Full Text] [Related]
20. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
